Welcome Message

On behalf of the organizing committee of Global Novel Vaccine R&D Summit, we are proud to announce that the summit will be held during November 12-13, 2022 in Shanghai, China. On this honorable occasion, we would like to invite you to give a presentation on your latest research.

With the fast development of genomics, humans begin to develop a genome-based vaccine development strategy, which is called reverse vaccinology. 5-valent rotavirus vaccine and live influenza vaccine are developed through new reverse vaccine technology. Since the outbreak of COVID-19, the development of nucleic acid vaccine has been promoted. Among them, the mRNA vaccine showed a better protection rate than other types of vaccines. In addition, new vaccine technologies such as synthetic peptide vaccine, anti-idiotypic antibody vaccine and plant-based vaccine have emerged.

In order to explore and learn the technical route of new vaccines, build a communication platform for scientific researchers and research institutions, deepen academic exchanges and industrial cooperation, promote the R & D process of new vaccines and benefit human health, the organizing committee will strongly invite international and domestic leading vaccine experts, vaccine entrepreneurs and heads of disease control departments to present wonderful reports, and invite upstream and downstream enterprises of the industrial chain to attend the exhibition.

Finally, we cordially hope all the friends and colleagues who may concern to join us together, to make the summit a big success.